Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Precision Therapeutics Inc. (AIPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,160
  • Shares Outstanding, K 11,800
  • Annual Sales, $ 650 K
  • Annual Income, $ -7,750 K
  • 36-Month Beta 1.05
  • Price/Sales 21.63
  • Price/Cash Flow N/A
  • Price/Book 2.72

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.08 +9.26%
on 07/02/18
1.58 -25.32%
on 07/13/18
+0.10 (+9.26%)
since 06/20/18
3-Month
0.81 +45.50%
on 04/23/18
1.58 -25.32%
on 07/13/18
+0.29 (+32.58%)
since 04/20/18
52-Week
0.81 +45.68%
on 04/04/18
2.50 -52.80%
on 11/01/17
-0.34 (-22.37%)
since 07/20/17

Most Recent Stories

More News
Precision Therapeutics Merger with Helomics Corp. Accelerates Personalized Cancer Treatment Strategies

In an Interview with CEOCFO Magazine, CEO Dr. Carl Schwartz Explains how the Company's Database of Tumors, Artificial Intelligence Technology, and Groundbreaking Method for Growing Human Cancer Cells Makes...

AIPT : 1.18 (-1.67%)
Precision Therapeutics Signs Definitive Merger Agreement with Helomics Holding Corporation

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, is pleased to announce that...

AIPT : 1.18 (-1.67%)
Precision Therapeutics Launches New Website

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that it has...

AIPT : 1.18 (-1.67%)
Precision Therapeutics Reports First Quarter 2018 Financial Results

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today financial results...

AIPT : 1.18 (-1.67%)
Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery and producer of the FDA-approved...

AIPT : 1.18 (-1.67%)
Technical Perspectives on Medical Supplies Stocks -- OraSure Technologies, Precision Therapeutics, Retractable Technologies, and Tandem Diabetes Care

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on OSUR, AIPT, RVP, and TNDM which can be accessed for free by signing up to www.wallstequities.com/registration....

AIPT : 1.18 (-1.67%)
OSUR : 16.93 (+0.12%)
TNDM : 26.89 (+1.05%)
RVP : 0.83 (-1.19%)
Precision Therapeutics, Inc. Signs Letter of Intent to Purchase Remainder of Helomics Corporation Shares

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that it has...

AIPT : 1.18 (-1.67%)
Precision Therapeutics, Inc. Engages Richard Gabriel to Drive Business Development Strategy for its TumorGenesis Subsidiary

Precision Therapeutics Inc. (NASDAQ:AIPT) ("Precision" or "the Company"), formerly Skyline Medical, a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced...

AIPT : 1.18 (-1.67%)
SKLN : 1.21 (-11.03%)
CORRECTING and REPLACING - Precision Therapeutics Releases Highlights from FY 2017 Business Update Call

In a release issued under the same headline earlier today by Precision Therapeautics (NASDAQ:AIPT), please note that the forward-looking statements paragraph was missing. The corrected release follows:...

AIPT : 1.18 (-1.67%)
SKLN : 1.21 (-11.03%)
Precision Therapeutics is the First Company to Grow Cancer Cells in the Lab That React Like Tumors Inside the Body -- CEOLIVE.TV

CEOLive.TV, a news organization that highlights leading CEOs, companies, and industry experts for investors, today released a video interview with Dr. Carl Schwartz, CEO of Precision Therapeutics Inc (NASDAQ:AIPT),...

AIPT : 1.18 (-1.67%)
SKLN : 1.21 (-11.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade AIPT with:

Business Summary

Precision Therapeutics Inc. operating business areas includes development of a healthcare CRO which provides personalized medicine solutions for clients in the pharmaceutical, diagnostic and biotech industries as well as production of the FDA-approved STREAMWAY(R) System for automated, direct-to-drain...

See More

Key Turning Points

2nd Resistance Point 1.27
1st Resistance Point 1.23
Last Price 1.18
1st Support Level 1.15
2nd Support Level 1.11

See More

52-Week High 2.50
Fibonacci 61.8% 1.85
Fibonacci 50% 1.65
Fibonacci 38.2% 1.46
Last Price 1.18
52-Week Low 0.81

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar